Home > Boards > Canadian > Cannabis > Aphria Inc (TSX:APH)

From today's Financial Times:

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
john1311 Member Profile
Member Level 
Followed By 13
Posts 1,560
Boards Moderated 1
Alias Born 10/19/15
160x600 placeholder
Aphria signs exclusive agreement with Argentina-based importer to supply medical cannabis in Argentina PR Newswire (Canada) - 3/21/2018 9:00:00 AM
Nuuvera announces shareholder approval of plan of arrangement with Aphria Inc. PR Newswire (Canada) - 3/20/2018 5:47:00 PM
Preparation Continues for Expanding Legalized Cannabis Market in Canada NetworkNewsWire - 3/20/2018 8:45:00 AM
Aphria receives third-party independent GMP certification of Leamington growing and processing facilities PR Newswire (Canada) - 3/16/2018 7:00:00 AM
Aphria's Australian-based partner Althea receives Medical Cannabis License for cultivation PR Newswire (Canada) - 3/15/2018 7:00:00 AM
Aphria More Than Triples Production Capacity with Health Canada Approval for Part III Expansion PR Newswire (Canada) - 3/13/2018 7:00:00 AM
Aphria Amends Arrangement Agreement with Nuuvera PR Newswire (Canada) - 2/20/2018 7:00:00 AM
Aphria signe une lettre d'intention avec la SAQ en vue de fournir jusqu'à 12 000 kg de cannabis annuellement au marché Qué... PR Newswire (Canada) - 2/14/2018 6:45:00 AM
Aphria signs letter of intent with SAQ to supply up to 12,000 kg of cannabis annually to Quebec market PR Newswire (Canada) - 2/14/2018 6:45:00 AM
Aphria announces closing of Broken Coast Cannabis acquisition PR Newswire (Canada) - 2/13/2018 8:00:00 AM
Aphria begins to divest of its equity investment in passive US assets PR Newswire (Canada) - 2/5/2018 7:00:00 AM
Aphria and Liberty Health Sciences Announce Definitive Agreement for Sale of Aphria's Investment in Copperstate Farms to Libe... PR Newswire (Canada) - 2/2/2018 8:00:00 AM
Aphria considers strategic alternatives for its US cannabis interests PR Newswire (Canada) - 2/1/2018 11:32:00 AM
Global leader in medical cannabis created by Aphria and Nuuvera combination PR Newswire (Canada) - 1/29/2018 7:00:00 AM
Nuuvera and Aphria finalize offtake agreement for extra 60,000 kgs of cannabis production PR Newswire (Canada) - 1/19/2018 8:30:00 AM
Fertile Ground for Canadian Cannabis Producers NetworkNewsWire - 1/16/2018 8:45:00 AM
Aphria strengthens portfolio with acquisition of leading West Coast producer Broken Coast PR Newswire (Canada) - 1/15/2018 8:00:00 AM
Aphria Continues Expansion into Australia with Strategic Investment in Althea Company Pty Ltd. PR Newswire (Canada) - 1/15/2018 7:00:00 AM
Aphria increases revenue 39% and Kilograms(1) sold 45% in quarter PR Newswire (Canada) - 1/10/2018 8:00:00 AM
Aphria secures additional 120,000 kgs of expected annual cannabis production for January 2019(1) PR Newswire (Canada) - 1/8/2018 8:00:00 AM
Aphria Announces Closing of Bought Deal Financing PR Newswire (Canada) - 1/3/2018 9:30:00 AM
L'OCRCVM permet la reprise de la négociation - WEED; APH PR Newswire (Canada) - 12/29/2017 12:43:00 PM
IIROC Trade Resumption - WEED: APH PR Newswire (Canada) - 12/29/2017 12:39:00 PM
Suspension de la négociation par l'OCRCVM - WEED; APH PR Newswire (Canada) - 12/29/2017 12:35:00 PM
IIROC Trading Halt - WEED; APH PR Newswire (Canada) - 12/29/2017 12:31:00 PM
john1311 Member Level  Thursday, 10/05/17 04:33:12 AM
Re: Goodbuddy4863 post# 705
Post # of 894 

From today's Financial Times:

As of Sep 29, 2017, the consensus forecast amongst 8 polled investment analysts covering Aphria Inc advises investors to purchase equity in the company. This has been the consensus forecast since the sentiment of investment analysts improved on Aug 16, 2017. The previous consensus forecast advised that Aphria Inc would outperform the market.

On Jul 12, 2017, Aphria Inc reported 4th quarter 2017 losses of -0.02 per share. This result was in line with the consensus of the 3 analysts following the company and under-performed last year's 4th quarter results by -0.04.
The next earnings announcement is expected on Oct 05, 2017.

The 10 analysts offering 12 month price targets for Aphria Inc have a median target of 8.63, with a high estimate of 13.00 and a low estimate of 6.75. The median estimate represents a 17.51% increase from the last price of 7.34.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
Current Price
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist